NL950027I1 - Alpha-halomethyl-alpha-amino acid derivatives and pharmaceutical preparation containing them. - Google Patents
Alpha-halomethyl-alpha-amino acid derivatives and pharmaceutical preparation containing them.Info
- Publication number
- NL950027I1 NL950027I1 NL950027C NL950027C NL950027I1 NL 950027 I1 NL950027 I1 NL 950027I1 NL 950027 C NL950027 C NL 950027C NL 950027 C NL950027 C NL 950027C NL 950027 I1 NL950027 I1 NL 950027I1
- Authority
- NL
- Netherlands
- Prior art keywords
- alpha
- halomethyl
- amino acid
- acid derivatives
- pharmaceutical preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/08—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81476577A | 1977-07-11 | 1977-07-11 | |
| US2875779A | 1979-04-10 | 1979-04-10 | |
| US2875879A | 1979-04-10 | 1979-04-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL950027I1 true NL950027I1 (en) | 1996-02-01 |
| NL950027I2 NL950027I2 (en) | 1997-06-02 |
Family
ID=27363337
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7807453A NL190662C (en) | 1977-07-11 | 1978-07-11 | alpha-Halo-methyl-alpha-amino acid derivatives and pharmaceutical composition containing them. |
| NL950027C NL950027I2 (en) | 1977-07-11 | 1995-11-17 | Alpha-halomethyl-alpha-amino acid derivatives and pharmaceutical preparation containing them. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7807453A NL190662C (en) | 1977-07-11 | 1978-07-11 | alpha-Halo-methyl-alpha-amino acid derivatives and pharmaceutical composition containing them. |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS5419913A (en) |
| AU (1) | AU522660B2 (en) |
| BE (3) | BE868882A (en) |
| CA (1) | CA1091661A (en) |
| CH (1) | CH642055A5 (en) |
| DE (1) | DE2828739A1 (en) |
| FR (1) | FR2430418A1 (en) |
| GB (1) | GB2001960B (en) |
| NL (2) | NL190662C (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4399151A (en) | 1980-06-16 | 1983-08-16 | Merrell Dow Pharmaceuticals Inc. | Method of inhibiting the growth of protozoa |
| SE460517B (en) | 1980-06-16 | 1989-10-23 | Merrell Pharma Inc | USE OF A COMPOSITION FOR THE PREPARATION OF A MEDICINE FOR THE TREATMENT OF INFECTIONS CAUSED BY TRYPANOSOMA BRUCEI |
| GB2083030B (en) * | 1980-08-23 | 1984-03-07 | Merrell Toraude & Co | Fluorinated pentene diamine derivatives |
| ZA815808B (en) * | 1980-08-23 | 1982-08-25 | Merrell Toraude & Co | Fluorinated pentene diamine derivatives |
| US4437873A (en) | 1981-03-23 | 1984-03-20 | Merrell Dow Pharmaceuticals Inc. | Method of inhibiting algae |
| US4423073A (en) * | 1981-08-19 | 1983-12-27 | Merrell Toraude Et Compagnie | Fluorinated diaminopentene derivatives |
| US4446151A (en) * | 1981-08-19 | 1984-05-01 | Merrell Toraude Et Compagnie | Decarboxylase-inhibiting fluorinated pentane diamine derivatives |
| US4435425A (en) | 1982-04-09 | 1984-03-06 | Merrell Toraude Et Compagnie | Fluorinated diaminobutane derivatives |
| JPS62148462A (en) * | 1985-12-19 | 1987-07-02 | メレルダウフア−マス−テイカルズ インコ−ポレ−テツド | Novel method of controlling growth of protozoa |
| ATE77367T1 (en) * | 1988-02-05 | 1992-07-15 | Merrell Dow Pharma | 5-SUBSTITUTED ORNITHINE DERIVATIVES. |
| CA1319123C (en) * | 1988-08-31 | 1993-06-15 | Andrew T. Au | Method for the production of (-) 2-substituted-ornithines |
| US6103220A (en) * | 1998-01-23 | 2000-08-15 | Levine; Martin | Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease |
| US6187296B1 (en) | 1998-01-23 | 2001-02-13 | The Board Of Regents Of The University Of Oklahoma | Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease |
| US7015349B2 (en) | 2003-03-26 | 2006-03-21 | The Gillette Company | Reduction of hair growth |
| US20230218644A1 (en) | 2020-04-16 | 2023-07-13 | Som Innovation Biotech, S.A. | Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR64495B (en) * | 1977-06-01 | 1980-03-31 | Merck & Co Inc | Novel fluorinated amino acids |
-
1978
- 1978-06-07 CA CA304,918A patent/CA1091661A/en not_active Expired
- 1978-06-21 AU AU37327/78A patent/AU522660B2/en not_active Expired
- 1978-06-27 GB GB7827967A patent/GB2001960B/en not_active Expired
- 1978-06-30 DE DE19782828739 patent/DE2828739A1/en active Granted
- 1978-07-10 CH CH746678A patent/CH642055A5/en not_active IP Right Cessation
- 1978-07-10 FR FR7820517A patent/FR2430418A1/en active Granted
- 1978-07-10 BE BE189191A patent/BE868882A/en not_active IP Right Cessation
- 1978-07-11 NL NL7807453A patent/NL190662C/en not_active IP Right Cessation
- 1978-07-11 JP JP8361978A patent/JPS5419913A/en active Granted
-
1980
- 1980-01-17 BE BE0/199012A patent/BE881209A/en not_active IP Right Cessation
- 1980-01-17 BE BE0/199011A patent/BE881208A/en not_active IP Right Cessation
-
1995
- 1995-11-17 NL NL950027C patent/NL950027I2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2430418A1 (en) | 1980-02-01 |
| FR2430418B1 (en) | 1984-07-13 |
| AU3732778A (en) | 1980-01-03 |
| GB2001960A (en) | 1979-02-14 |
| JPH0122259B2 (en) | 1989-04-25 |
| DE2828739A1 (en) | 1979-02-01 |
| CH642055A5 (en) | 1984-03-30 |
| NL190662C (en) | 1994-06-16 |
| BE881208A (en) | 1980-05-16 |
| BE881209A (en) | 1980-05-16 |
| NL7807453A (en) | 1979-01-15 |
| AU522660B2 (en) | 1982-06-17 |
| GB2001960B (en) | 1982-02-24 |
| CA1091661A (en) | 1980-12-16 |
| NL950027I2 (en) | 1997-06-02 |
| JPS5419913A (en) | 1979-02-15 |
| BE868882A (en) | 1978-11-03 |
| NL190662B (en) | 1994-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL7801187A (en) | PHARMACEUTICAL TABLET. | |
| NL7808125A (en) | PHARMACEUTICAL PREPARATIONS OF ALUMINUM SALTS OF IBUPROPHENE. | |
| DK541878A (en) | PHTHALAZINE-4-YLEDICIC ACID DERIVATIVES | |
| NL190519B (en) | 4-SUBSTITUTED PHENYLACACIC ACID COMPOUNDS, AND PHARMACEUTICAL PREPARATIONS. | |
| BE871584A (en) | PHARMACEUTICAL PREPARATIONS | |
| NL7811692A (en) | PHENYLGLYCIN DERIVATIVES AND PREPARATIONS CONTAINING THEM. | |
| NL950027I1 (en) | Alpha-halomethyl-alpha-amino acid derivatives and pharmaceutical preparation containing them. | |
| NL190520B (en) | PLACE 1 SUBSTITUTED, 7-SUBSTITUTED AMINO-6-HALOGEN-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBONIC ACIDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM. | |
| NL7803162A (en) | NEW 1-AMINOINDA DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM. | |
| SE7809373L (en) | PHARMACEUTICAL USE 5-HYDROXY-1H-IMIDAZOLE-4-CARBOXAMIDE DERIVATIVES | |
| NL188645C (en) | 1-AZAXANTHON-3-CARBONIC ACID COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS. | |
| NL7711446A (en) | PHARMACEUTICAL DISINFECTING PREPARATION. | |
| NL7806528A (en) | PREPARATION OF SALPETERIC ACID. | |
| NO147437C (en) | PARTICULAR SUBSTANCE FOR DRUGS. | |
| IT7821686A0 (en) | PHARMACEUTICAL COMPOSITION. | |
| NL7900264A (en) | 4-PYRIDONE-3-CARBONIC ACID DERIVATIVES AND THEIR PREPARATION. | |
| NL980017I1 (en) | Anti-hypertensive oral pharmaceutical preparation. | |
| NL7801921A (en) | PHARMACEUTICAL PREPARATIONS. | |
| NL7804887A (en) | BISAMIDINE COMPOUNDS, THEIR PREPARATION, AND PHARMACEUTICAL MIXTURES CONTAINING THEM. | |
| IT7825570A0 (en) | ANTICANCER SUBSTANCE AND PROCEDURE FOR ITS PREPARATION. | |
| NL7807871A (en) | ALPHA-HALOGEN METHYLAMINOIC ACID DERIVATIVES. | |
| NL184896C (en) | PYRANOCHINOLIN DERIVATIVES AND FORMED PHARMACEUTICAL PREPARATIONS CONTAINING THESE. | |
| NL7808440A (en) | ANTI-INFLAMMATORY 1-PHENYLETHANOLAMINE DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AND METHODS FOR PREPARATION THEREOF. | |
| NL7801576A (en) | BENZOHETEROCYCLYLGLYOXYL ACID DERIVATIVES. | |
| NL7805158A (en) | PHARMACEUTICAL PREPARATION. |